Pfizer Inc. PFE
29.37 USD -0.08 (-0.27%)
Nov 6, 2026, 3:10 PM EST
28.54 Day range 29.43
23.67 52-week range 30.79
- YTD
- +17.95%
- 1 year
- +18.19%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 62.58B | 63.63B | 59.55B | 101.17B | 81.29B | |
| 62.58B | 63.63B | 59.55B | 101.17B | 81.29B | |
| 16.07B | 17.85B | 24.95B | 34.34B | 30.82B | |
| 46.51B | 45.78B | 34.60B | 66.83B | 50.47B | |
| 38.99B | 37.75B | 33.54B | 32.10B | 26.16B | |
| 10.44B | 10.82B | 10.68B | 11.43B | 10.36B | |
| 13.79B | 14.73B | 14.77B | 13.68B | 12.70B | |
| 7.52B | 8.02B | 1.06B | 34.73B | 24.31B | |
| -266.00M | -28.00M | -1.11B | 3.33B | 1.85B | |
| 7.77B | 8.03B | 2.12B | 31.37B | 21.98B | |
| 7.77B | 8.03B | 2.12B | 31.37B | 21.98B | |
| 7.77B | 8.03B | 2.12B | 31.37B | 21.98B | |
| 7.81B | 8.06B | 2.16B | 31.41B | 22.02B | |
| -25.00M | -11.00M | 15.00M | -6.00M | 434.00M | |
| 41.00M | 31.00M | 39.00M | 35.00M | 45.00M | |
| 1.37 | 1.42 | 0.38 | 5.59 | 3.92 | |
| 1.37 | 1.42 | 0.38 | 5.59 | 3.92 | |
| 1.36 | 1.41 | 0.37 | 5.47 | 3.85 | |
| 1.72 | 1.68 | 1.64 | 1.60 | 1.56 | |
| 7.50B | 8.00B | 1.00B | 34.70B | 23.83B | |
| 7.50B | 8.00B | 1.00B | 34.70B | 23.83B | |
| 5.68B | 5.66B | 5.64B | 5.61B | 5.60B | |
| 5.71B | 5.70B | 5.71B | 5.73B | 5.71B |